Skip to content

An external application and internal medicine for varicose vein, drug Zanthoxylum Rhetsa bark powder

An analytical study on Zanthoxylum Rhetsa (ROXB) DC And its Clinical Efficacy in Siraja Granthi (Varicose vein) - nil

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/12/060456
Enrollment
200
Registered
2023-12-04
Start date
Unknown
Completion date
Unknown
Last updated
2023-12-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I839- Asymptomatic varicose veins of lower extremities

Interventions

None listed

Sponsors

Dr Subrahmanya Padyana
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: patients suffering from Siraja granthi only lower limbs grade 0-4 grade

Exclusion criteria

Exclusion criteria: pregnantwomen, patients with other systemic disorders , bleeding disorders patient indicated for surgery

Design outcomes

Primary

MeasureTime frame
Subjective parameters such as shoola, kandu, daha and objective parameters like shoth tortusity and skin changes are gradewise notedTimepoint: 0 day medicine given 7th day 14th day 28th day follow up period 42day

Secondary

MeasureTime frame
curative of varicosity of lower limbsTimepoint: 24th & 42nd day

Countries

India

Contacts

Public ContactDr Subrahmanya Padyana

Alvas Ayurveda Medical College Moodbidri

drsp28@gmail.com9448327156

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026